109 related articles for article (PubMed ID: 9233830)
1. TGFbeta regulation of mitogen-activated protein kinases in human breast cancer cells.
Frey RS; Mulder KM
Cancer Lett; 1997 Jul; 117(1):41-50. PubMed ID: 9233830
[TBL] [Abstract][Full Text] [Related]
2. Involvement of extracellular signal-regulated kinase 2 and stress-activated protein kinase/Jun N-terminal kinase activation by transforming growth factor beta in the negative growth control of breast cancer cells.
Frey RS; Mulder KM
Cancer Res; 1997 Feb; 57(4):628-33. PubMed ID: 9044838
[TBL] [Abstract][Full Text] [Related]
3. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
Chuang SM; Wang IC; Yang JL
Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
[TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis by DPC4, a transcriptional factor regulated by transforming growth factor-beta through stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) signaling pathway.
Atfi A; Buisine M; Mazars A; Gespach C
J Biol Chem; 1997 Oct; 272(40):24731-4. PubMed ID: 9312063
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element.
Newberry EP; Willis D; Latifi T; Boudreaux JM; Towler DA
Mol Endocrinol; 1997 Jul; 11(8):1129-44. PubMed ID: 9212060
[TBL] [Abstract][Full Text] [Related]
6. The extracellular-signal-regulated protein kinases (Erks) are required for UV-induced AP-1 activation in JB6 cells.
Huang C; Ma WY; Dong Z
Oncogene; 1999 May; 18(18):2828-35. PubMed ID: 10362253
[TBL] [Abstract][Full Text] [Related]
7. Role of Ras and Mapks in TGFbeta signaling.
Mulder KM
Cytokine Growth Factor Rev; 2000; 11(1-2):23-35. PubMed ID: 10708950
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of rat hepatocyte proliferation by transforming growth factor beta and glucagon is associated with inhibition of ERK2 and p70 S6 kinase.
Dixon M; Agius L; Yeaman SJ; Day CP
Hepatology; 1999 May; 29(5):1418-24. PubMed ID: 10216124
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of the P-450 side chain cleavage enzyme (CYP11A1) promoter through ras- and Ets-2-signaling pathways.
Pestell RG; Albanese C; Watanabe G; Lee RJ; Lastowiecki P; Zon L; Ostrowski M; Jameson JL
Mol Endocrinol; 1996 Sep; 10(9):1084-94. PubMed ID: 8885243
[TBL] [Abstract][Full Text] [Related]
10. Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells.
Chen YQ; Sloan-Lancaster J; Berg DT; Richardson MA; Grinnell B; Tseng-Crank J
Thromb Haemost; 2001 Dec; 86(6):1563-72. PubMed ID: 11776328
[TBL] [Abstract][Full Text] [Related]
11. Age-related decline in mitogen-activated protein kinase activity in epidermal growth factor-stimulated rat hepatocytes.
Liu Y; Guyton KZ; Gorospe M; Xu Q; Kokkonen GC; Mock YD; Roth GS; Holbrook NJ
J Biol Chem; 1996 Feb; 271(7):3604-7. PubMed ID: 8631968
[TBL] [Abstract][Full Text] [Related]
12. Decline of shear stress-induced activation of extracellular signal-regulated kinases, but not stress-activated protein kinases, in in vitro propagated endothelial cells.
Hu Y; Hochleitner BW; Wick G; Xu Q
Exp Gerontol; 1998 Sep; 33(6):601-13. PubMed ID: 9789737
[TBL] [Abstract][Full Text] [Related]
13. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
14. Activation of mitogen-activated protein kinases by green tea polyphenols: potential signaling pathways in the regulation of antioxidant-responsive element-mediated phase II enzyme gene expression.
Yu R; Jiao JJ; Duh JL; Gudehithlu K; Tan TH; Kong AN
Carcinogenesis; 1997 Feb; 18(2):451-6. PubMed ID: 9054642
[TBL] [Abstract][Full Text] [Related]
15. Essential role of mitogen-activated protein kinase pathway and c-Jun induction in epidermal growth factor-induced gene expression of human 12-lipoxygenase.
Chen BK; Kung HC; Tsai TY; Chang WC
Mol Pharmacol; 2000 Jan; 57(1):153-61. PubMed ID: 10617690
[TBL] [Abstract][Full Text] [Related]
16. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation.
Watts RG; Huang C; Young MR; Li JJ; Dong Z; Pennie WD; Colburn NH
Oncogene; 1998 Dec; 17(26):3493-8. PubMed ID: 10030673
[TBL] [Abstract][Full Text] [Related]
17. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway.
Hocevar BA; Brown TL; Howe PH
EMBO J; 1999 Mar; 18(5):1345-56. PubMed ID: 10064600
[TBL] [Abstract][Full Text] [Related]
18. Altered transforming growth factor signaling in epithelial cells when ras activation is blocked.
Hartsough MT; Frey RS; Zipfel PA; Buard A; Cook SJ; McCormick F; Mulder KM
J Biol Chem; 1996 Sep; 271(37):22368-75. PubMed ID: 8798398
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.
Putz T; Culig Z; Eder IE; Nessler-Menardi C; Bartsch G; Grunicke H; Uberall F; Klocker H
Cancer Res; 1999 Jan; 59(1):227-33. PubMed ID: 9892211
[TBL] [Abstract][Full Text] [Related]
20. Requirement of TGF-beta receptor-dependent activation of c-Jun N-terminal kinases (JNKs)/stress-activated protein kinases (Sapks) for TGF-beta up-regulation of the urokinase-type plasminogen activator receptor.
Yue J; Sun B; Liu G; Mulder KM
J Cell Physiol; 2004 May; 199(2):284-92. PubMed ID: 15040011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
